Skip to content

Unique Product Handling Experience

Specialized Handling for Hormones, Alcohol-Containing & High-Potency Products

CPL is equipped to manage complex, higher-risk semi-solid and non-sterile liquid products, including male and female hormones, corticosteroids, alcohol-containing, light-sensitive, and select high-potency compounds. Dedicated suites and equipment, XP-rated environments for alcohol products, and contained isolators for male and female hormones, as well as Safebridge category 3 APIs, help protect patients and personnel. Robust PPE, engineered air handling, and disciplined procedures ensure compliant, segregated manufacturing without compromising quality or cross-contamination control.

Controlled Containment & Manufacturing for High-Risk Products

Explore our specialized manufacturing and containment capabilities for challenging drug products, including hormones, corticosteroids, HPAPIs (high-potency active pharmaceutical ingredients), alcohol-based formulations, and light-sensitive compounds, ensuring safety, compliance, and product integrity at every step.

Male & Female Hormone Handling Expertise

CPL offers specialized capabilities for the handling and manufacturing of hormone-based drug products, including both male and female hormones, a somewhat rare and differentiating capability in the semi-solid CDMO space. Dedicated suites and equipment are used to prevent cross-contamination, with separate areas for male and female hormone products. For high-potency compounds like estradiol, CPL uses negative-pressure isolators to ensure containment and operator safety, while maintaining strict environmental controls in line with cGMP, ISO, and other regulatory expectations.

High-Potency API (HPAPI) Management

We are equipped to safely manage highly potent compounds, including Category 3 APIs per Safebridge classification. Handling is performed under containment using negative pressure isolators (glove boxes) to prevent operator exposure. Staff wear full PPE (personal protective equipment), including Tyvek® suits, gloves, and powered air-purifying respirators (PAPRs). Dedicated suites feature independent air handling systems and stringent engineering controls to minimize cross-contamination and ensure cGMP-compliant handling of high-potency drug substances.

Alcohol-Based Product Manufacturing Capabilities

Our GMP facility is equipped to safely manufacture alcohol-containing semi-solid and liquid drug products in dedicated explosion-proof (XP-rated) suites designed for flammable solvents. All processing equipment is XP-rated and grounded in accordance with regulatory safety standards to mitigate ignition risks. Dedicated storage areas ensure compliant handling and inventory management of ethanol and other volatile solvents. With robust safety protocols, specialized infrastructure, and proven expertise, CPL supports formulation, scale-up, and packaging of alcohol-based products with confidence and regulatory compliance.

Light-Sensitive Semi-Solid & Non-Sterile Liquid Manufacturing

CPL is equipped to manufacture and package light-sensitive semi-solid and liquid drug products under controlled lighting conditions to prevent photodegradation. Specialized production suites utilize yellow lighting, UV-filtered fixtures, and light-restrictive packaging to protect product integrity during processing and storage. From formulation through final packaging, CPL follows strict cGMP protocols for light-sensitive APIs, ensuring compliance with regulatory requirements and preserving the stability, safety, and efficacy of finished drug products throughout the product lifecycle.

CPL Experience Spotlight

Safely Scaling an Alcohol-Based Product

A client needed to scale production of an alcohol-based oral product requiring stringent safety and containment measures. Due to the flammability and explosion risks, most CDMOs lacked the specialized infrastructure and protocols necessary to handle such materials at commercial scale.

Unique Product Capabilities At-a-Glance

CPL combines specialized containment infrastructure, robust GMP systems, and full lifecycle development expertise to safely manufacture and scale challenging semi-solid and non-sterile liquid drug products.

Product and formulation optimization

Process characterization and PPQ

Analytical method validation

Late-phase product testing & registration support

Late-phase clinical manufacturing

Packaging and labeling

Containment and handling of demanding drug products: Hormones, alcohol-based, light- and temperature-sensitive

Skin Lab, skin testing services

Supporting Technologies & Facilities

40,000 ft2 laboratory space with state-of-the art analytical instrumentation

Pilot manufacturing suite (batch sizes from 20kg to 300kg)

State-of-the-art analytical instrumentation

140,000 ft2 GMP manufacturing

Intrinsically-safe (XP) suites

(8) GMP suites

Mixing kettles from 20kg to 5,000kg

Temperature control (heating/cooling capabilities)

Nitrogen blanketing

Dedicated to Excellence
from Molecule to Commercialization

CPL supports programs from early-phase through commercial launch, combining preformulation insight, robust semi-solid and non-sterile liquid development, scalable process design, and clinical and commercial manufacturing.

Pharmaceutical Development Services Icon

Pharmaceutical Development Services

Analytical & Product Testing Icon

Analytical & Product Testing

Clinical & Commercial Manufacturing Icon

Clinical & Commercial Manufacturing

Packaging, Labeling & Serialization Icon

Packaging, Labeling & Serialization

Semi-Solid & Non-Sterile Liquid Expertise Icon

Semi-Solid & Non-Sterile Liquid Expertise

Unique Product Handling Experience Icon

Unique Product Handling Experience

Concept to Commercial Capabilities Icon

Concept to Commercial Capabilities

Regulatory Classification-Specific Strategies Icon

Regulatory Classification-Specific Strategies

FAQs

Explore answers to the most frequently asked questions about the handling of challenging-to-manage semi-solids and non-sterile liquid drug products.
  • CPL has the rare ability to manufacture both male and female hormone-based drug products, as well as a variety of corticosteroids. Dedicated suites and equipment are used for each hormone type to prevent cross-contamination. Estradiol products, due to their high potency, are handled under containment using negative-pressure isolators. Strict cleaning validation, personnel controls, and segregated workflows support compliance and product integrity.

  • Alcohol-containing semi-solids and non-sterile liquids are manufactured in intrinsically safe (XP-rated) suites using XP-rated equipment. Grounding procedures are strictly followed to prevent static discharge and ignition risks. CPL also maintains dedicated, compliant storage areas for flammable solvents such as ethanol, ensuring full compliance with safety and regulatory guidelines.

  • For compounds classified as Category 3 under Safebridge standards, CPL utilizes negative-pressure isolators (glove boxes) to weigh and wet APIs under containment. Personnel are equipped with Tyvek® suits, gloves, and powered air-purifying respirators (PAPRs), while dedicated suites feature independent air-handling systems to minimize cross-contamination and protect operator safety, in accordance with cGMP.

  • CPL employs controlled lighting environments, including yellow light and UV-filtered fixtures, to protect light-sensitive APIs from photodegradation. Packaging processes use light-restrictive materials to maintain stability at every stage, from formulation through final packaging, in alignment with cGMP standards to ensure the safety, efficacy, and shelf life of these products.

Commitment.
Partnership. Legacy.

Leverage CPL’s 35 years of expertise in non-sterile liquids and semi-solids to ensure your program's success. We’ll support your product from molecule to market, or step in at any stage of its product lifecycle.

man